Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), the most commonly reported adverse effects of retatrutide include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (most frequent, particularly during dose escalation) Injection site reactions: Redness, bruising, or mild discomfort Decreased appetite: Generally considered a therapeutic effect but can contribute to nutritional deficiency if severe Increased heart rate: Observed with glucagon receptor agonism
It can take time (sometimes weeks) for your brain to respond to the new dose
We also galvanized the clinical side to add their support to this initiative, all of which were instrumental in the code creation and adoption
It can take trial and error to find new portion sizes that work for your body on tirzepatide, so hang in there
The most rapid weight loss usually occurs during months two through six as doses increase and the medication reaches full therapeutic effect
